PathMaker Neurosystems is named as recipient of France’s top prize for innovation

BOSTON, MASSACHUSETTS, & PARIS, FRANCE, June 26, 2019 – PathMaker Neurosystems Inc. (“PathMaker”) is very pleased to announce that it has been named as the 2019 recipient of the CCI France International Trophy for Innovation at this year’s Trophées CCI France International. PathMaker Neurosystems, a clinical-stage bioelectronic medicine company developing breakthrough non- invasive systems for…

Details

Scientists discover autoimmune disease associated with testicular cancer

Using advanced technology, scientists at Chan Zuckerberg (CZ) Biohub, Mayo Clinic and University of California, San Francisco (UCSF), have discovered an autoimmune disease that appears to affect men with testicular cancer. Called “testicular cancer-associated paraneoplastic encephalitis,” the disease causes severe neurological symptoms in men. They progressively lose control of their limbs, eye movements, and, in…

Details

WVU researchers map crystals to advance treatments for stroke, diabetes, dementia

MORGANTOWN, W.Va.–Medications attach to the proteins in our bodies the way spacecrafts dock into the International Space Station. Describing that process in detail can reveal a lot about how the medications work–and what form new medications should take. Researchers at West Virginia University have mapped the crystal structure of a protein that resides in our…

Details